Liver Transplantation
📧 Sign up to get email alerts when something new happens for Liver Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2021-05-04Clinical Trial Update: Study to Evaluate Pharmacokinetic and Bioavailability of Envarsus® vs. Advagraf® in Liver Transplant Recipients [Phase 3]
A Phase 3 study comparing pharmacokinetics and bioavailability of Envarsus vs. Advagraf in liver transplant recipients has completed.
-
FDA approval · 2021-04-21FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for mycophenolate mofetil from Accord Healthcare Inc., authorizing the generic product's continued m…
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation [Phase 2]
A Phase 2 clinical trial evaluating donor-specific immune senescence and exhaustion as biomarkers of tolerance after liver transplantation h…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients [Phase 4]
A Phase 4 trial assessing the efficacy and safety of ADVAGRAF after prior tacrolimus treatment in new liver transplant recipients has comple…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Evaluate the Efficacy and Safety of the ADVAGRAF® [Phase 4]
Phase 4 clinical trial evaluating efficacy and safety of ADVAGRAF in liver transplantation recipients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-01-15FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves a supplemental application for mycophenolate mofetil from Hikma Pharmaceuticals USA Inc., reflecting a labeling update for this…
-
FDA approval · 2021-01-15FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare Inc.'s mycophenolic acid, supporting its continued regulatory status as a gene…
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant [Phase 2, Phase 3]
A clinical trial update evaluating the clinical benefits of EnvarsusXR in post-liver transplant patients (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients [Phase 2]
Phase 2 trial comparing sotrastaurin-tacrolimus to mycophenolic acid-tacrolimus in de novo liver transplant patients, assessing efficacy, sa…
-
FDA approval · 2020-08-04FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for mycophenolate mofetil, a generic immunosuppressant used to prevent organ transplant rejecti…
-
FDA approval · 2020-08-04FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for Mycophenolate mofetil filed by Strides Pharma Science Limited.
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantation [Phase 4]
Phase 4 trial updating treatment of anemia with intravenous iron in patients listed for liver transplantation, related to liver transplantat…
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation [Phase 1]
Phase 1 trial investigating donor-derived alloantigen-reactive regulatory T cells (darTregs) in liver transplantation; study terminated with…
-
CLINICAL_TRIALS trial_result · 2020-06-05Clinical Trial Update: Twice-daily Tacrolimus and Everolimus Convert to Once-daily Tacrolimus and Everolimus in Liver Transplant Recipient [Phase 4]
Phase 4 trial updating dosing from twice-daily to once-daily tacrolimus and everolimus in liver transplant recipients, completed.
-
CLINICAL_TRIALS trial_result · 2020-06-05Clinical Trial Update: A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant [Phase 4]
A Phase 4 clinical trial evaluating patient adherence and convenience to immunosuppressive agents in newly transplanted liver transplant rec…
-
CLINICAL_TRIALS trial_result · 2020-01-30Clinical Trial Update: HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102 [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial update for GC1102 in HBV-associated liver transplant patients.
-
FDA approval · 2019-10-22FDA Approved: TACROLIMUS — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for tacrolimus (generic) under ANDA 091195, enabling continued approval of a …
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Efficacy of Low-dose Dexmedetomidine to Prevent Delirium in Liver Transplant Patients [Phase 4]
Phase 4 trial assessing low-dose dexmedetomidine to prevent delirium after liver transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of cryosurgery and NK cell immunotherapy for liver tumors in patients with liver transplantatio…
-
FDA approval · 2019-09-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare Inc.'s mycophenolate mofetil. This action updates the regulatory status for th…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation [Phase 2]
Phase 2 pharmacogenetic trial of tacrolimus after pediatric transplantation completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL) [Phase 4]
Phase 4 clinical trial update assessing efficacy and safety of once-daily tacrolimus in liver transplant recipients.
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: The Effect of Remote Ischemic Preconditioning in Living Donor Hepatectomy [NA]
Clinical trial update on remote ischemic preconditioning in living donor hepatectomy; study completed and results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Study to Assess the Effect of Intravenous Supplementation of Omega-3 Fatty Acids on Outcome of Recipients in Living Donor Liver Transplantation [Phase 2]
Phase 2 trial investigating intravenous omega-3 fatty acid supplementation in recipients of living donor liver transplantation.
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients [Phase 4]
Phase 4 trial update on combining everolimus with tacrolimus in liver transplant recipients; results completed and posted in 2019.